India Considers Grants To Private Firms That Find Disease Cures
This article was originally published in PharmAsia News
India is considering creation of an $11 million grant program for drug makers in private industry that develop drugs for major tropical diseases such as tuberculosis. The grant system for private sector companies would be in addition to grants for public-funded research industries and soft loans already allowed to private companies. The Cabinet Committee on Economic Affairs has received a proposal from the Department of Science and Technology, which runs the grant program for public institutions. Targeted diseases include malaria and leprosy in addition to TB. (Click here for more
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.